Status:

COMPLETED

Emotion Awareness and Skills Enhancement Program

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

University of Alabama at Birmingham

Conditions:

Autism Spectrum Disorder

Eligibility:

All Genders

12-21 years

Phase:

NA

Brief Summary

This project will address impaired emotion regulation in adolescents with ASD (autism spectrum disorder). There are no evidence-based interventions to improve emotion regulation (ER) in this populatio...

Detailed Description

The current study is to test a new intervention called Emotional Awareness and Skills Enhancement (EASE). This program was designed to address ASD-specific obstacles to effective emotion regulation, s...

Eligibility Criteria

Inclusion

  • ages 12-21 years, inclusive
  • A diagnosis of ASD (autism spectrum disorder), as defined by exceeding the ASD cutoff on the ADOS-2 (Autism Diagnostic Observation Scale) or ADI-R (Autism Diagnostic Interview-Revised) In. If the participant has completed the ADOS in a previous study within 3 years and signs a release of information to obtain it, they will not be required to complete another ADOS.
  • Average verbal intellectual ability (Wechsler Abbreviated Scale of Intelligence-2 \[WASI-2\] FSIQ \>=75).
  • Fluent in the English language
  • Problems with regulating emotions based on parent report 6) Parent/guardian who will attend sessions and assessments.

Exclusion

  • Current concerns of suicidality that warrants immediate clinical care (such potential participants will be referred elsewhere for treatment), determined by clinical interview.
  • Previous or current diagnosis of a psychotic disorder.
  • Receiving concurrent psychotherapy treatment for emotional issues (i.e., depression, anxiety, anger) that overlaps with the current study. This will be assessed using current treatment items on the demographic forms.

Key Trial Info

Start Date :

January 30 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 30 2024

Estimated Enrollment :

113 Patients enrolled

Trial Details

Trial ID

NCT03432832

Start Date

January 30 2018

End Date

July 30 2024

Last Update

April 17 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of Alabama

Tuscaloosa, Alabama, United States, 35487

2

Shannondora Porton

Pittsburgh, Pennsylvania, United States, 15213